Toshihiro Inoue, MD, graduated from School of Medicine, Kumamoto University, Japan in 1997, and chose the ophthalmologist residency in Kumamoto University Hospital. From 1999 to 2001, he was a clinical fellow in Department of Ophthalmology, Kitasato University Hospital, Japan. In 2006, he gained PhD in Department of Cell Fate Modulation, Kumamoto University, where he published basic articles relating to development and regeneration of retina. Then he became a research fellow in Department of Ophthalmology, Duke University, USA, from 2006 to 2008, where he published basic articles about trabecular aqueous outflow system. Since 2008, he has been an assistant professor in Department of Ophthalmology, Faculty of Life Sciences, Kumamoto University, Japan, and has engaged in both clinical works and basic researches as an clinician scientists. The specialty of Dr. Inoue is glaucoma, and a board member of Japan Glaucoma Society since 2014. He has been published both clinical and basic articles that clarified the role of ROCK inhibitor in glaucoma pathology. He has been also interested in molecular mechanisms of tissue fibrosis after glaucoma filtration surgery, and explored molecular targets to improve surgical results. As a clinician, he conducted more than 370 ocular surgeries including about 150 glaucoma filtration surgeries per year. He received prizes including Imai Award in 2010, Suda Award of Japan Glaucoma Society in 2011, Young Investigator Award of Glaucoma Summer Camp in 2013, Medical Research Encouragement Priza of The Japan Medical Association in 2016.